Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−126.29 MXN
−310.65 M MXN
0.00 MXN
9.89 M
About PaxMedica, Inc.
Sector
Industry
CEO
Howard J. Weisman
Website
Headquarters
Tarrytown
Founded
2018
FIGI
BBG01BWS0079
PaxMedica, Inc. is a clinical stage biopharmaceutical company. It engages in the business of developing drug candidates for the treatment of autism spectrum disorder, Fragile X syndrome tremor-ataxia, and Human African Trypanosomiasis. The company was founded by Michael L. Derby on April 5, 2018 and is headquartered in Tarrytown, NY.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange PAXMEDICA, INC stocks are traded under the ticker PXMD.
Yes, you can track PAXMEDICA, INC financials in yearly and quarterly reports right on TradingView.
PAXMEDICA, INC is going to release the next earnings report on Nov 15, 2024. Keep track of upcoming events with our Earnings Calendar.
PXMD net income for the last quarter is −54.98 M MXN, while the quarter before that showed −61.21 M MXN of net income which accounts for 10.16% change. Track more PAXMEDICA, INC financial stats to get the full picture.
No, PXMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 16, 2024, the company has 7.00 employees. See our rating of the largest employees — is PAXMEDICA, INC on this list?
Like other stocks, PXMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PAXMEDICA, INC stock right from TradingView charts — choose your broker and connect to your account.